These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 32418263)

  • 1. Neonatal diabetes due to potassium channel mutation: Response to sulfonylurea according to the genotype.
    Garcin L; Mericq V; Fauret-Amsellem AL; Cave H; Polak M; Beltrand J
    Pediatr Diabetes; 2020 Sep; 21(6):932-941. PubMed ID: 32418263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Genetics, Clinical Characteristics, and Treatment Outcomes of K
    Ngoc CTB; Dien TM; De Franco E; Ellard S; Houghton JAL; Lan NN; Thao BP; Khanh NN; Flanagan SE; Craig ME; Dung VC
    Front Endocrinol (Lausanne); 2021; 12():727083. PubMed ID: 34566892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study.
    Bowman P; Sulen Å; Barbetti F; Beltrand J; Svalastoga P; Codner E; Tessmann EH; Juliusson PB; Skrivarhaug T; Pearson ER; Flanagan SE; Babiker T; Thomas NJ; Shepherd MH; Ellard S; Klimes I; Szopa M; Polak M; Iafusco D; Hattersley AT; Njølstad PR;
    Lancet Diabetes Endocrinol; 2018 Aug; 6(8):637-646. PubMed ID: 29880308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of permanent neonatal diabetes in Slovakia and successful replacement of insulin with sulfonylurea therapy in KCNJ11 and ABCC8 mutation carriers.
    Stanik J; Gasperikova D; Paskova M; Barak L; Javorkova J; Jancova E; Ciljakova M; Hlava P; Michalek J; Flanagan SE; Pearson E; Hattersley AT; Ellard S; Klimes I
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1276-82. PubMed ID: 17213273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfonylurea in the treatment of neonatal diabetes mellitus children with heterogeneous genetic backgrounds.
    Zhang M; Chen X; Shen S; Li T; Chen L; Hu M; Cao L; Cheng R; Zhao Z; Luo F
    J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):877-84. PubMed ID: 25781672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and molecular characterization of neonatal diabetes and monogenic syndromic diabetes in Asian Indian children.
    Jahnavi S; Poovazhagi V; Mohan V; Bodhini D; Raghupathy P; Amutha A; Suresh Kumar P; Adhikari P; Shriraam M; Kaur T; Das AK; Molnes J; Njolstad PR; Unnikrishnan R; Radha V
    Clin Genet; 2013 May; 83(5):439-45. PubMed ID: 22831748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional characterization of activating mutations in the sulfonylurea receptor 1 (ABCC8) causing neonatal diabetes mellitus in Asian Indian children.
    Balamurugan K; Kavitha B; Yang Z; Mohan V; Radha V; Shyng SL
    Pediatr Diabetes; 2019 Jun; 20(4):397-407. PubMed ID: 30861254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and genetic features of Argentinian children with diabetes-onset before 12months of age: Successful transfer from insulin to oral sulfonylurea.
    Taberner P; Flanagan SE; Mackay DJ; Ellard S; Taverna MJ; Ferraro M
    Diabetes Res Clin Pract; 2016 Jul; 117():104-10. PubMed ID: 27329029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfonylurea for improving neurological features in neonatal diabetes: A systematic review and meta-analyses.
    de Gouveia Buff Passone C; Giani E; Vaivre-Douret L; Kariyawasam D; Berdugo M; Garcin L; Beltrand J; Bernardo WM; Polak M
    Pediatr Diabetes; 2022 Sep; 23(6):675-692. PubMed ID: 35657808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes.
    Babiker T; Vedovato N; Patel K; Thomas N; Finn R; Männikkö R; Chakera AJ; Flanagan SE; Shepherd MH; Ellard S; Ashcroft FM; Hattersley AT
    Diabetologia; 2016 Jun; 59(6):1162-6. PubMed ID: 27033559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and clinical features of K
    Hashimoto Y; Dateki S; Hirose M; Satomura K; Sawada H; Mizuno H; Sugihara S; Maruyama K; Urakami T; Sugawara H; Shirai K; Yorifuji T
    Pediatr Diabetes; 2017 Nov; 18(7):532-539. PubMed ID: 27681997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal diabetes: an expanding list of genes allows for improved diagnosis and treatment.
    Greeley SA; Naylor RN; Philipson LH; Bell GI
    Curr Diab Rep; 2011 Dec; 11(6):519-32. PubMed ID: 21993633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case report: Better late than never, but sooner is better: switch from CSII to sulfonylureas in two patients with neonatal diabetes due to KCNJ11 variants.
    Mancioppi V; Pozzi E; Zanetta S; Missineo A; Savastio S; Barbetti F; Mellone S; Giordano M; Rabbone I
    Front Endocrinol (Lausanne); 2023; 14():1143736. PubMed ID: 37251668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful sulfonylurea treatment of a neonate with neonatal diabetes mellitus due to a novel missense mutation, p.P1199L, in the ABCC8 gene.
    Oztekin O; Durmaz E; Kalay S; Flanagan SE; Ellard S; Bircan I
    J Perinatol; 2012 Aug; 32(8):645-7. PubMed ID: 22842804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful transition to sulfonylurea therapy in two Iraqi siblings with neonatal diabetes mellitus and iDEND syndrome due to ABCC8 mutation.
    Ozsu E; Giri D; Seymen Karabulut G; Senniappan S
    J Pediatr Endocrinol Metab; 2016 Dec; 29(12):1403-1406. PubMed ID: 27849623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age at the time of sulfonylurea initiation influences treatment outcomes in KCNJ11-related neonatal diabetes.
    Thurber BW; Carmody D; Tadie EC; Pastore AN; Dickens JT; Wroblewski KE; Naylor RN; Philipson LH; Greeley SA;
    Diabetologia; 2015 Jul; 58(7):1430-5. PubMed ID: 25877689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights into K
    Pipatpolkai T; Usher S; Stansfeld PJ; Ashcroft FM
    Nat Rev Endocrinol; 2020 Jul; 16(7):378-393. PubMed ID: 32376986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical presentation and long-term outcome of patients with KCNJ11/ABCC8 variants: Neonatal diabetes or MODY in the DPV registry from Germany and Austria.
    Warncke K; Eckert A; Kapellen T; Kummer S; Raile K; Dunstheimer D; Grulich-Henn J; Woelfle J; Wenzel S; Hofer SE; Dost A; Holl RW
    Pediatr Diabetes; 2022 Nov; 23(7):999-1008. PubMed ID: 35822653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and Molecular Characterization of Children with Neonatal Diabetes Mellitus at a Tertiary Care Center in Northern India.
    Jain V; Satapathy A; Yadav J; Sharma R; Radha V; Mohan V; De Franco E; Ellard S
    Indian Pediatr; 2017 Jun; 54(6):467-471. PubMed ID: 28667717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early transition from insulin to sulfonylureas in neonatal diabetes and follow-up: Experience from China.
    Li X; Xu A; Sheng H; Ting TH; Mao X; Huang X; Jiang M; Cheng J; Liu L
    Pediatr Diabetes; 2018 Mar; 19(2):251-258. PubMed ID: 28791793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.